Introduction
The AGA Council section "Cellular & Molecular Gastroenterology" (CMG) has broad interests in the basic mechanisms underlying digestive diseases and gastrointestinal biology. The section's membership has interests representing many areas of cutting-edge science, including growth factors, stem cells, cellular differentiation, epigenetics, mechanisms of receptor function, basic physiology and cell biology, luminal chemosensing, intestinal inflammation, and mucosal injury and healing. CMG strives to invite outside speakers who are leading scientists in their fields to present forward-looking scientific programming at DDW.
We have an exciting lineup for DDW 2017. CMG will sponsor a distinguished abstract plenary session, 3 research symposia, 1 state-of-the-art hybrid session, 6 research fora, and 11 poster sessions. In addition, CMG will sponsor a special Funderburg Symposium celebrating the 25 th anniversary of this award. We look forward to seeing you at DDW!
Research Fora
Topical Research Fora have been organized based on the top-scored abstracts. Three of the 6 are cross-sectional, drawing abstracts from several sections. Themes this year focus on gastrointestinal stem cell function in homeostasis and disease, basic mechanisms of enteric function, inflammation and cancer, and novel animal models of GI disorders.
Saturday, May 6, 2017: "Intestinal Stem Cell Biology" and "Human Organoid Models of Gut Function and Pathogenesis"
Monday, May 8, 2017: "Basic Mechanisms in Enteric Neurosciences" and "Inflammatory Mechanisms Regulating Colitis"
Tuesday, May 9, 2017: "In Vivo (Non-Human) Models of Gastrointestinal Disorders" and "Molecular and Cellular Mechanisms of GI Cancers"
Monday, May 8, 2017 : "Mechanisms of Bile Acids in Intestinal Disorders." This symposium will examine the physiology and pathophysiology of bile acids, with experts in the field presenting current understanding of the novel regulators of homeostasis, metabolism and inflammation. Presenters include: Thomas Vallim, David J. Mangelsdorf and Michael Trauner.
Poster Sessions
CMG is sponsoring 11 poster sessions. Saturday, May 6, 2017: "Stem Cells and Organoids," "Cellular Plasticity and Growth Factors Regulating Proliferation and Differentiation," "Gastric Neoplasms: Biology and Clinical Therapeutics. " Sunday, May 7, 2017 : "Basic Mechanisms of Injury and Repair", "In Vivo Models of Gastrointestinal Disorders," "Transcriptional and Epigenetic Regulation of GI Function and Disease."
Monday, May 8, 2017: "Cell Signaling in Inflammation", "Enteric Neuroscience and Chemosensing in The GI Tract," "Genetics and Intestinal Disorders."
Tuesday, May 9, 2017: "Cell Biology, Biochemistry and Integrative Biology," "Signaling Pathways Regulating Motility, Secretion and Absorption".
Funderburg Symposium
Sunday, May 7, 2017: "Funderburg Symposium: 25 Years of Gastric Cancer Research." This symposium will celebrate 25 years of the R. Robert & Sally Funderburg Research Award in Gastric Cancer. James Goldenring will give an overview of the important impact this award has had on discoveries in the field. In addition, the three most recent awardees will present their research findings, including: Manual Amieva, who will speak on Helicobacter colonization of the gastric stem cell niche; Linda Samuelson, who will present her work on Notch pathway induction of gastric tumorigenesis; and Richard DiPaolo, who will describe research on chronic gastritis and gastric cancer.
Introduction
The EGD section continues to heavily contribute to the educational and research mission of the AGA Institute and remains a highly visible section at Digestive Disease Week® (DDW). The attendance at DDW continues to be robust, with nearly all of the EGD section's clinical sessions exceeding expected capacity. The section is diverse in regards to representation of multiple upper GI diseases including esophagus, stomach, and duodenum. Advances continue to develop in the area of esophageal reflux and motility testing (e.g., high resolution manometry and mucosal impedance measurements), endoscopic reflux therapies as well as continued strong interest in both clinical and basic research in Eosinophilic esophagitis, Barrett's esophagus, and H. pylori-related complications. Dominant areas of investigation in this section include esophageal physiologic testing, eosinophilic esophagitis, H. pylori infection and its chronic implications, GERD and extraesophageal GERD, Barrett's esophagus, esophageal and gastric dysmotility, and GI bleeding. Section leaders believe the EGD section will continue to play a pivotal role in providing excellence in research and education, and strive to meet these goals by thoughtful programming.
Research Fora
The EGD section will feature 10 research fora, which will have oral abstract presentations and invited speakers centered on general themes. These include the following:
Saturday, May 6, 2017: "GERD: Diagnostic Testing," "Mechanisms of Host Mucosal Response to Injury and H. pylori Infection" and "New Insights Into the Pathogenesis and Treatment of Eosinophilic Esophagitis" Sunday, May 7, 2017: "Barrett's Esophagus: Diagnosis, Management and Surveillance" and "GERD and Barrett's Esophagus: Medical, Surgical and Endoscopic Therapies"
Monday, May 8, 2017: "GERD: Complications and Extraesophageal Presentations" and "Peptic Ulcer Disease and Non-Variceal UGI Bleeding" Tuesday, May 9, 2017: "H. pylori Epidemiology, Outcomes, and Treatment," "GERD, Achalasia and EOE" and "Advances in the Diagnosis and Treatment of Eosinophilic Esophagitis"
Distinguished Abstract Plenary
The EGD section will hold its distinguished abstract plenary, Esophageal, Gastric & Duodenal Disorders Distinguished Abstract Plenary: The Best of Barrett's, EoE, GERD, H. pylori, on Tuesday, May 9. The session will include the presentation of the 2017 EGD Section Research Mentor Award to Dr. Prateek Sharma, MD, at the beginning of this session. 
Symposia

Introduction
The Gastrointestinal Oncology Section is dedicated to expanding and advancing the science and practice of gastroenterology primarily by providing educational leadership in topics central to the initiation, progression, diagnosis and treatment of gastrointestinal tract cancers by programming high quality and the latest advances in clinical, translational, and basic science research. The foci of our section are divided under two broad, inter-related themes of organ systems and gastrointestinal cancer biology.
Research Fora
The Gastrointestinal Oncology Research Fora were developed to include many of the most outstanding abstracts submitted to our section for presentation in Chicago. Fora topics reflect the most current research interests of our section members, and bring together thematically related abstracts to foster greater interactions between presenters and the audience.
Saturday, May 6, 2017: "Clonal and Stem Cell Populations in GI Carcinogenesis," "Translational and Targeted Therapies for GI Cancers," "Inflammation and inflammatory pathways in GI carcinogenesis" and "Gastric Neoplasms: Precursor Lesions, Biology, Diagnosis and Clinical Therapeutics"
Sunday, May 7, 2017: "Cancer Epidemiology and Genetics" and "Cancer Microenvironment and Models"
Monday, May 8, 2017: "Cancer Therapy and Chemoprevention" and "Barrett's Esophagus and Esophageal Adenocarcinoma-Mechanisms and Models" Tuesday, May 9, 2017: "Carcinoid and Other GI Neuroendocrine Tumors (Genetics, Epigenetics, Cell Biology and Development)" and "Colon Cancer Biomarkers and Screenings"
Distinguished Abstract Plenary
The Gastrointestinal Oncology Distinguished Abstract Plenary is delighted to present six outstanding abstracts. Topics will be of interest to clinicians as well as basic scientists and will explore novel biomarkers, habits associated with colon cancer survival, and mechanisms of carcinogenesis.
Monday, May 8, 2017: "Gastrointestinal Oncology Distinguished Abstract Plenary and Section Business Meeting." Anyone interested in supporting the section's mission, invigorating our outreach, or ideas for 2018 DDW Symposia topics should attend.
Symposia
The invited speaker symposia this year are an exciting collection of cutting-edge basic research methodologies and forward-looking clinical reviews designed to provoke discussion and debate.
Saturday, May 6, 2017: "The Tumor Microenvironment (TME): Novel Pathways Driving Carcinogenesis" Sunday, May 7, 2017: "Using CRISPR/Cas9 to Develop Novel Models for GI Cancer"
Monday, May 8, 2017: "Early Onset and Hereditary Colorectal Cancer," "Esophageal Squamous Cell Cancers: From Genomic Landscapes to Perspectives on New Therapies" and "Systems Biology Approaches to Gastrointestinal Cancer" Tuesday, May 9, 2017: "U.S. and International Colorectal Cancer Screening Guidelines"
Poster Sessions
GIONC is sponsoring 16 poster sessions. The topics include the following:
"Gastric Neoplasms: Precursor Lesions, Biology, Diagnosis and Clinical Therapeutics Inflammation and GI Cancers," "Pancreatic Neoplasms: Precursors, Biology, Diagnosis and Therapy, "Metabolism, Obesity, Microbiome, and Nutrition in GI Cancer Pathogenesis," "Liver and Biliary Carcinoma: Management, Etiology, Diagnosis and Natural History," "Biomarkers for Detection, Treatment and Prognosis of GI Cancers," "Translational and Targeted Therapies for GI Cancers Canceromics: Cancer Genomics, Epigenomics, Metabolomics, Proteomics and Systems Biology," "Tumor Cell Biology and Microenvironment," "Familial Cancer Syndromes and Cancer Genetics," "Cancer Prevention and Chemoprevention Esophageal and Junctional Neoplasms: Precursor Lesions, Biology, Diagnosis and Clinical Therapeutics," "Carcinoid and Neuroendocrine Neoplams: Biology, Diagnosis and Clinical Therapeutics," "Molecular Mechanisms and Pathways in Carcinogenesis and Metastasis," "Colon Cancer Screening," "Epidemiology and Population Health Screening: Colorectal Cancer, Esophageal Cancer, Hepatocellular Carcinoma, Other Screening".
Other Events
Gastroenterology Research Group (GRG) Spring Symposium
We encourage GI Oncology members to attend the GRG Symposium on Sunday, May 7, 2017 entitled "Engineered T cells and immune check point therapies for GI cancers" to hear about the one of the latest advances in therapy for GI cancers.
GIONC 2017 
Research Mentor Award
Established in 2010, the Research Mentor Award recognizes an individual for his or her achievements as an outstanding mentor in a specific area of research.
The award will be presented to Jun Yu, MD, PhD, AGAF during Gastrointestinal Oncology Distinguished Abstract Plenary and Section Business Meeting, Monday, May 8, 4-5:30 p.m., 4:00-4:06 PM, S105bcd
Growth, Development and Child Health Section Noah F. Shroyer, PhD, and Maria Oliva-Hemker, MD
Introduction
The Growth, Development & Child Health (GDCH) section serves dual roles in both attracting basic scientists focused on the biological pathways that regulate the growth, development and differentiation of the gastrointestinal tract as well as clinicians interested in gastrointestinal diseases affecting the pediatric population.
Research Fora
The GDCH section will feature 5 fora, the majority of which will showcase both abstract and invited presentations. 
Research Mentor Award
The 
Introduction
The IMIBD section executes the AGA's strategic plan by providing an international forum to present and evaluate the most exciting and innovative research in the field. By providing a forum for debate, collaboration and an exchange of ideas, the IMIBD section helps define what is state-of-theart care in IBD and pushes the boundaries of science in search of a cure. Established and emerging leaders collate this information to provide education and training to both the next generation of researchers as well as for providers caring for patients with IBD. This enhanced knowledge leads to improved practice and quality, ultimately showing the value of section through the work of its diverse members. 
Research Fora
Introduction
The Intestinal Disorders section represents a community of clinical, translational and basic scientists interested in disease-focused and pathway-driven processes underlying: Celiac disease and food intolerances; Radiation, chemotherapy, and hypoxia-induced injury and repair; Diarrhea, malabsorption and enteropathies.
Microbial pathogenesis and mechanisms of microbe-host cross talk; Nutrient, solute, salt and water transport; Epithelial cell and molecular biology; Epithelial barrier function and wound repair; Epithelial functions in innate immunity and inflammation; and Irritable bowel syndrome. The Intestinal Disorders section aims to foster collaboration among interactive scientific communities by featuring outstanding basic, translational and clinical research in these areas. 
Research Fora
Introduction
The Liver & Biliary (LB) section is dedicated to advancing the science and clinical practice of gastroenterology by providing leadership in topics central to the epidemiology, diagnosis and treatment of acute and chronic hepatobiliary diseases. The section is focused on providing state-of-the-art programming in all aspects of clinical, translational and basic science research as it relates to liver disease and transplantation. It is the second largest section in the AGA Council, and collaborates with multiple AGA sections and the American Association for the Study of Liver Diseases (AASLD) in offering abstract-driven sessions at DDW. 
Research Fora
The MMDGT is offering 4 research sessions that feature outstanding speakers who will present findings that highlight emerging areas of discovery that advance our understanding of the role of the gut microbiome in health and disease. MMDGT is also happy to co-sponsor many sessions this year as the microbiome is a cross cutting field of interest that goes beyond this section. Please be sure to use the mobile planner and app once its available to see all the MMDGT related sessions. 
Symposia
The MMDGT symposia will feature outstanding speakers, selected abstract-driven talks, and topics in formats that provides attendees with what's current and hot, but also a look into the future of the microbiome field. A mix of basic science, translational, and clinical topics will be presented.
Saturday, May 6, 2017: "At the Frontier of Microbiome Research" (A potpourri of some of the most exciting microbiome research selected by MMDGT) and "Dietary Modulation of Host-Microbe Interactions in Health and Disease" (Diet is a major determinant of gut microbial composition and function. Speakers will discuss how diet-induced changes in gut microbiota affect health and disease and how this knowledge can be leveraged for therapeutic purposes)
Sunday, May 7, 2017: "Gut Microbiota in Disease; Identifying Personalized Approaches in Management of Disease and Section Business Meeting" (A stellar cast of leading clinical and basic researchers who will provide a snapshot of microbiome-based approaches and interventions for personalized medicine. This session will be followed by the business meeting of the MMDGT where the MMDGT Research Mentor Award will be presented to John F. Cryan, PhD.
Monday, May 8, 2017: "Dark Matter: Non-Bacterial Kingdoms of the Microbiome (Bacteriophage, Archea, and Fungi)" (Bacteria are only one group of microbes that comprise the gut microbiome. Come learn about the less well known microbial kingdoms that may be important to health and disease) and "Unraveling Extra-Intestinal HostMicrobiome Systems Biology: Terra Incognita to Cognita" (If you want to learn how to study the gut microbiome, this is the session to come to. The session feature some of the best work in this area, where experimental, bioinformatics, and clinical tools have been applied to gain insights into human health and diseases)
Tuesday, May 9, 2017: "Clostridium difficile Colitis: When Good Bugs Go Bad" (Understand microbial therapies and learn about microbiota functions and host-microbe interactions in C. difficile colitis), "Gut Feelings: The Microbiome-Gut-Brain Axis" (Learn about the many ways that gut microbes regulate central and peripheral organ functions, affecting processes relevant to IBS, metabolic diseases, and IBD) and "Lessons from Childhood -The Role of the Gut Microbiome in Pediatric Diseases" (Learn about how childhood development is impacted by changes in the gut microbiome and what long term consequences may be)
Research Mentor Award
The award will be presented to John F. Cryan, PhD during Gut Microbiota in Disease; Identifying Personalized Approaches in Management of Disease and Section Business Meeting, Sunday, May 7, 2-3:30 p.m. 2:00-2:06 PM, S102abc (TS)
Introduction
The NGM section of the AGA Council is dedicated to serving the field of Neurogastroenterology and Gastrointestinal Motility by promoting excellence in research, innovation, education and training. Some of the sections' main goals are:
1. To attract the best science and cutting-edge research in neurogastroenterology and GI motility for presentation at Digestive Disease Week® (DDW).
2. To educate and train gastroenterologists, research scientists, surgeons, physiologists, trainees, nurses and technicians on the latest developments in the field.
3. To foster interdisciplinary basic science, translational and clinical research.
4. To lead and critically examine the development of novel tools for studying neurogastroenterology and motility disorders, and gut and brain interactions, both at the bench side and for patient care.
The NGM Section presents several unique scientific sessions on hot topics and cutting-edge research at DDW 2017. A new distinguished feature for 2017 is the Josephine & Michael Camilleri MD Lecture that will be presented in an interactive clinical symposium on Sunday, May 7, 2017. The following are some highlights.
Research Fora
There are several ground-breaking and novel research fora in which cutting-edge science will be discussed. These include joint sessions co-sponsored by other sections. NGM introduces a novel feature comprising of state-of-the-art lectures at the end of each oral abstract session that aims to summarize and bring together the latest advances in the field by an international expert.
Saturday, May 6, 2017: On this day there are three research fora sessions, where several abstracts from three broad fields will be presented, each followed by state-of-theart presentations:
"Novel Diagnostic Approaches and Treatment of Anorectal Dysmotility" followed by the 
Distinguished Abstract Plenary
On Sunday, May 7, 2017, do not miss the best and most outstanding research in the field that will be presented at this NGM distinguished plenary session. Attendees will be able to listen and deliberate the most significant advance from bench to translational to clinical neurogastroenterology and motility. In Addition, they will see the presentation of the 2017 Research Mentor Award to Dr. Raj Kumar Goyal, MD, in the middle of this session. 
Symposia
Poster Sessions
The poster sessions remain extremely popular with attendees and will cover a wide range of cutting-edge topics and will also include poster tours by experts.
Sessions will be held every day from Saturday, May 6 to Tuesday, May 9, 2017, and will cover an array of topics.
Saturday, May 6, 2017: Topics covered will include the following: Anorectal Dysmotility; Esophageal Motility and Dysmotility; Oropharyngeal Dysmotility. Tuesday, May 9, 2017: Posters presented on this day will include the following: Brain-Gut Axis; Enteric Neurobiology: Cell and Molecular Biology; Functional Dyspepsia.
Research Mentor Award
The award will be presented to Raj Kumar Goyal, MD during Neurogastroenterology & Motility Distinguished Abstract Plenary, Sunday, May 7, [4] [5] In recent years, DDW programming by the Obesity, Metabolism and Nutrition (OMN) section has emphasized subject areas that have appealed to a majority of meeting attendees, especially those affiliated not only with the OMN section, but also other sections with which we share common interests, as reflected by our strong participation in cross-sectional programming. Our programming includes fora and symposia highlighting related topics, including bariatric surgery, GI neuroendocrinology and metabolism, new and innovative endoscopic and other treatments of obesity and diabetes, fatty liver disease, GI regulation of energy balance, weight and metabolic function, microbiota and metabolic regulation, and nutrition and metabolism across the life cycle. Nutritional support in all of its forms used in the management of a variety of diseases, including obesity, intestinal failure and inflammatory bowel disease, as well as nutrient absorption and metabolism, have also continued to be the focus of OMN programming. The OMN section has also endeavored to strike a balance between basic research to shed light on disease mechanisms, including pre-clinical studies to develop new therapies, and clinical and translational research to better describe disease phenotypes and test new therapeutic approaches.
Introduction
The Pancreatic Disorders (PAN) Section is dedicated to presenting the most up-to-date clinical and basic science information to as many dedicated members as possible. It provides an all-inclusive group of experts as speakers, who are whetted out by large number of stakeholders and peer reviewed on the best platform in the world.
Members will be heard on this platform for their needs, views and aspirations.
The section has made significant strides in the last two years by increasing the abstract submission by roughly 30 percent and by increasing membership and international participation. This was done through a broad inclusion of numerous colleagues in a variety of roles, including serving as poster judges serving on poster rounds and as advisory councillors. The section has continued to focus on translational sessions (highly popular clinical topics with cutting-edge basic science counterparts) to increase basic science membership and participation.
The creation of NIH-focused themes and participation from NIH speakers will help lead to in more NIH funding for pancreatic diseases. The best clinical and basic science research and symposia should be in the AGA Pancreatic Disorders section. Additionally, the section should include the best junior and senior GI talent in the word.
